Abhijit Lele &Amp; Sohini Das

Stories by Abhijit Lele &Amp; Sohini Das

Govt now allows doorstep delivery of drugs

Govt now allows doorstep delivery of drugs

Rediff.com   27 Mar 2020

Medicines that fall under Schedule H category (class of prescription drugs) would be provided against a valid prescription that can be submitted either physically or over e-mail. Narcotics, psychotropics and controlled substances, though, cannot be delivered.

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Rediff.com   20 Mar 2020

Retailers and multiplex operators want mall owners to either forgo rent for the period of the shutdown or lower rent in the event the mall is open but footfalls are low.

How companies deal with coronavirus panic

How companies deal with coronavirus panic

Rediff.com   17 Mar 2020

Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.

Coronavirus fear robs malls, multiplexes of Holi colour

Coronavirus fear robs malls, multiplexes of Holi colour

Rediff.com   8 Mar 2020

'There is a clear business impact. People are avoiding crowded places and gatherings across cities. This is hitting business, both at traditional and modern trade outlets, during the Holi season, which kicked off from Saturday,' says Praveen Khandelwal, general secretary, Confederation of All India Traders (CAIT).

SBI to invest up to Rs 10,000 cr in Yes Bank

SBI to invest up to Rs 10,000 cr in Yes Bank

Rediff.com   8 Mar 2020

Assuming the private bank issues 20 billion shares at Rs 10 apiece (with face value of Rs 2 each), the total capital raise will be Rs 20,000 crore. And for the 49 per cent stake, SBI will need to put in about Rs 10,000 crore.

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com   4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

RBI urges PSBs to take steps to increase credit growth

RBI urges PSBs to take steps to increase credit growth

Rediff.com   3 Mar 2020

Bank credit growth declined to 8.5 per cent in January from 13.5 per cent in the year-ago period.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com   20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Kohli is top celebrity brand for third time in a row

Kohli is top celebrity brand for third time in a row

Rediff.com   17 Feb 2020

The Duff & Phelps report shows that Virat Kohli has increased his brand value by 40 per cent to $237.5 million in 2019 and taken a huge lead with his closest rival, Akshay Kumar, ranked second.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com   12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com   12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

For LIC, road to bourses won't be easy

For LIC, road to bourses won't be easy

Rediff.com   10 Feb 2020

Amendment to the Act, sovereign guarantees, investment portfolio, realty holdings, and governance issues to shape valuation.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com   7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.

Bad debts: Banks may have to make provision for Rs 2.2 trn

Bad debts: Banks may have to make provision for Rs 2.2 trn

Rediff.com   16 Jan 2020

Bankers said they are looking outside the bankruptcy courts and will be able to resolve a few debts in the power sector before January-end.

Adamant Trai says will implement new tariff order by March 1

Adamant Trai says will implement new tariff order by March 1

Rediff.com   14 Jan 2020

Reiterating its position, TRAI, which oversees both the telecom and television sectors in the country, said the amendments suggested on January 1 had been done to correct "distortions" in the market and address pricing issues.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com   13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

How Avengers stole the Indian box office

How Avengers stole the Indian box office

Rediff.com   1 Jan 2020

'If you look at the Number 1 film in India this year across Bollywood and other regional film industries, it is Avengers: Endgame.'

PSBs need to build buffers to absorb shocks: Report

PSBs need to build buffers to absorb shocks: Report

Rediff.com   28 Dec 2019

Among the bank groups, under the baseline scenario, public sector banks' gross NPA ratios may increase to 13.2 per cent by September 2020 from 12.7 per cent in September 2019.

Slowdown blues: Bank credit growth will be lowest in 58 years

Slowdown blues: Bank credit growth will be lowest in 58 years

Rediff.com   27 Dec 2019

According to ICRA, even in a high-growth scenario, wherein the second half of FY20 sees the incremental bank credit rise to Rs 6.5-7 trn, there will still be a 40-45% year-on-year decline.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com   19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.